Informations:
Erreur:
Mots-clés
Primære neoplasmer i sentralnervesystemet ×
- Clinical Trial (106)
- Brain Neoplasms (102)
- Treatment Form (25)
- On-Study Form (12)
- Follow-Up Studies (11)
- Eligibility Determination (9)
- Baseline (6)
- Radiotherapy (5)
- Off-Treatment (5)
- Pathology (5)
- Adverse event (4)
- Registration (4)
- Laboratories (3)
- Leukemia (3)
- Quality of Life (2)
- Radiology (2)
- HIV Infections (2)
- Disease Response (2)
- Death (2)
- Questionnaires (1)
- Salvage Therapy (1)
- Disease Notification (1)
- Child (1)
- Symptom Assessment (1)
- Document Tracking (1)
- Drug trial (1)
- Parkinsons Disease (1)
- Demography (1)
- HIV (1)
- Neoplasms (1)
Table des matières
Modèles de données sélectionnés
Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.
106 Résultats de recherche.
Groupes Item: Header Module, HIV Viral Load
Groupes Item: Header Module, Missed Visit Information
Groupes Item: Header Module, Pharmacodynamics
Groupes Item: Header Module, Protocol Deviation
Groupes Item: Header, Neurologic Assessment, MENTAL STATUS, CRANIAL NERVES, MOTOR, Comments
Groupes Item: Stratification, Inclusion Criteria, Organ Function - Hematological, Organ Function - Non Hematological, Exclusion Criteria, Consents
Groupes Item: Header Module, General Information, DISEASE INFORMATION, PRE-STUDY SCANS, PRE-STUDY SCANS1, LOCATION OF PRIMARY, Baseline Lab Values, Systemic Treatment, SEVERE ACTIVE COMORBIDITY, Footer Module
Groupes Item: Header Module, Disease History, Maximum Diameter of Tumor on Pre-Operative Scan, Extent of Resection, Location of Primary Neoplasm, Side of Primary Tumor, Descriptive Factors
Groupes Item: Header, Treatment period, TUMOR EVALUATION, DISEASE STATUS, EVALUATIONS, SECOND LOOK SURGERY, SIGNIFICANT EVENTS DURING THIS REPORTING PERIOD, TREATMENT PLAN AFTER THIS TREATMENT PERIOD, TOXICITIES, Comments
Groupes Item: Header Module, T-Cell Laboratory Values, Comments
Groupes Item: Header Module, Inclusion Criteria, Exclusion Criteria, Consent For Participation in Pharmacogenetics Study and The Use Of Future Tissue Specimens, Comments
Groupes Item: Header Module, Specimen Procurement, Comments